These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29912696)

  • 1. Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada.
    Mahmud SM; Bozat-Emre S; Mostaço-Guidolin LC; Marrie RA
    Emerg Infect Dis; 2018 Jul; 24(7):1267-1274. PubMed ID: 29912696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
    Mahmud SM; Bozat-Emre S; Hammond G; Elliott L; Van Caeseele P
    PLoS One; 2015; 10(11):e0142754. PubMed ID: 26600435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
    De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
    JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.
    Mahmud SM; Van Caeseele P; Hammond G; Kurbis C; Hilderman T; Elliott L
    Emerg Infect Dis; 2012 May; 18(5):801-10. PubMed ID: 22516189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
    Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    Vaccine; 2013 Feb; 31(8):1246-54. PubMed ID: 23246544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic H1N1 Vaccination and Incidence of Acute Disseminated Encephalomyelitis in Manitoba.
    Jackson AC; Mostaço-Guidolin LC; Sinnock H; Bozat-Emre S; Routledge M; Mahmud SM
    Can J Neurol Sci; 2016 Nov; 43(6):819-823. PubMed ID: 27608932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway.
    Ghaderi S; Berg-Hansen P; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2020 Apr; 35(4):355-362. PubMed ID: 31873811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
    Weibel D; Sturkenboom M; Black S; de Ridder M; Dodd C; Bonhoeffer J; Vanrolleghem A; van der Maas N; Lammers GJ; Overeem S; Gentile A; Giglio N; Castellano V; Kwong JC; Murray BJ; Cauch-Dudek K; Juhasz D; Campitelli M; Datta AN; Kallweit U; Huang WT; Huang YS; Hsu CY; Chen HC; Giner-Soriano M; Morros R; Gaig C; Tió E; Perez-Vilar S; Diez-Domingo J; Puertas FJ; Svenson LW; Mahmud SM; Carleton B; Naus M; Arnheim-Dahlström L; Pedersen L; DeStefano F; Shimabukuro TT
    Vaccine; 2018 Oct; 36(41):6202-6211. PubMed ID: 30122647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.
    Moro ML; Nobilio L; Voci C; Di Mario S; Candela S; Magrini N;
    Vaccine; 2013 Feb; 31(10):1438-46. PubMed ID: 22885015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers.
    Kim WJ; Lee SD; Lee E; Namkoong K; Choe KW; Song JY; Cheong HJ; Jeong HW; Heo JY
    Vaccine; 2015 Sep; 33(38):4868-72. PubMed ID: 26238720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    Dodd CN; de Ridder M; Huang WT; Weibel D; Giner-Soriano M; Perez-Vilar S; Diez-Domingo J; Svenson LW; Mahmud SM; Carleton B; Naus M; Kwong JC; Murray BJ; Arnheim-Dahlstrom L; Pedersen L; Morros R; Puertas FJ; Black S; Sturkenboom M
    PLoS One; 2018; 13(10):e0204799. PubMed ID: 30332477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.
    Tacken MA; Jansen B; Mulder J; Visscher S; Heijnen ML; Campbell SM; Braspenning JC
    Vaccine; 2013 Jan; 31(6):900-5. PubMed ID: 23246546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada.
    Rouleau I; De Serres G; Skowronski DM; Drolet JP; Lemire C; Toth E; Landry M
    Vaccine; 2014 Jun; 32(28):3480-7. PubMed ID: 24793951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine.
    Magnus P; Gunnes N; Tveito K; Bakken IJ; Ghaderi S; Stoltenberg C; Hornig M; Lipkin WI; Trogstad L; Håberg SE
    Vaccine; 2015 Nov; 33(46):6173-7. PubMed ID: 26475444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Krause TG; Emborg HD; Melbye M; Hviid A
    JAMA; 2012 Jul; 308(2):165-74. PubMed ID: 22782418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
    Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.